India  

Bharat Biotech will involve 3,000 people for phase-III trials of COVID vaccine in UP

Video Credit: ANI - Duration: 01:36s - Published
Bharat Biotech will involve 3,000 people for phase-III trials of COVID vaccine in UP

Bharat Biotech will involve 3,000 people for phase-III trials of COVID vaccine in UP

Speaking on phase-III trials of the COVID-19 vaccine, Uttar Pradesh Health Minister Jai Pratap Singh on September 29 said Bharat Biotech will involve 3,000 people from the state- 1,500 each from Lucknow and Gorakhpur.

He said, "Phase-III trials of the COVID-19 vaccine being developed by Bharat Biotech will involve 3,000 people- 1,500 each from Lucknow and Gorakhpur."


You Might Like

Related news from verified sources

Bharat Biotech ties with WUSM for Covid vaccine

Vaccine major Bharat Biotech has joined hands with inked a licensing agreement with the Washington...
IndiaTimes - Published Also reported by •DNA


'Covaxin': Bharat Biotech's COVID-19 vaccine completes Phase-I trials at PGI Rohtak; here's when it will hit markets

The first phase of the clinical trials for Bharat Biotech's coronavirus disease (COVID-19) vaccine...
DNA - Published

Good news: Bharat Biotech’s ‘Covaxin’ to be tested for Phase-3 trials in Uttar Pradesh

In a good news for millions of Indians, the coronavirus COVID-19 vaccine ‘Covaxin’ will be tested...
Zee News - Published


Related videos from verified sources

New promising results from Moderna vaccine trial [Video]

New promising results from Moderna vaccine trial

Some promising news coming from the Moderna vaccine trial. Researchers say it appears to create a strong immune response in older people, as well as younger adults.

Credit: KTNV Channel 13 Las Vegas     Duration: 00:21Published
Covid vaccine: Covaxin phase 3 trials on 3,000 people in UP, says minister [Video]

Covid vaccine: Covaxin phase 3 trials on 3,000 people in UP, says minister

Hyderabad-based pharma company Bharat Biotech to conduct phase 3 clinical trial tests in October. Uttar Pradesh Health Minister Jai Pratap Singh said around 3,000 people to be tested under the phase 3..

Credit: HT Digital Content     Duration: 02:29Published
Moderna and Regeneron Jump on Positive Covid-19 Vaccine Trials [Video]

Moderna and Regeneron Jump on Positive Covid-19 Vaccine Trials

Biopharmaceutical giants Moderna and Regeneron lead other biotech companies higher after they each announce positive Covid-19 vaccine trial results.

Credit: The Street     Duration: 02:37Published